NO20022103L - New combination including a beta 2 (<beta>) 2 andrenoreceptor agonist and leukotriene receptor antagonist - Google Patents

New combination including a beta 2 (<beta>) 2 andrenoreceptor agonist and leukotriene receptor antagonist

Info

Publication number: NO20022103L
Authority: NO; Norway
Prior art keywords: beta; andrenoreceptor; agonist; receptor antagonist; combination including
Prior art date: 1999-11-03

Application number

NO20022103A

Other languages

Norwegian (no)

Other versions

NO20022103D0 (en

Inventor

Jan Trofast

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-11-03

Filing date

2002-05-02

Publication date

2002-05-02

2002-05-02 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2002-05-02 Publication of NO20022103L publication Critical patent/NO20022103L/en

2002-05-02 Publication of NO20022103D0 publication Critical patent/NO20022103D0/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Engineering & Computer Science (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Otolaryngology (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

NO20022103A 1999-11-03 2002-05-02 New combination including a beta 2 (<beta>) 2 andrenoreceptor agonist and leukotriene receptor antagonist NO20022103D0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9903995A SE9903995D0 (en)	1999-11-03	1999-11-03	New combination
PCT/SE2000/002115 WO2001032163A1 (en)	1999-11-03	2000-10-27	NEW COMBINATION COMPRISING A BETA 2 (β)2 ADRENO RECEPTOR AGONIST AND A LENKOTRIENE RECEPTOR ANTAGONIST

Publications (2)

Publication Number	Publication Date
NO20022103L true NO20022103L (en)	2002-05-02
NO20022103D0 NO20022103D0 (en)	2002-05-02

Family

ID=20417605

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20022103A NO20022103D0 (en)	1999-11-03	2002-05-02	New combination including a beta 2 (<beta>) 2 andrenoreceptor agonist and leukotriene receptor antagonist

Country Status (13)

Country	Link
EP (1)	EP1242065A1 (en)
JP (1)	JP2003513037A (en)
KR (1)	KR20020050254A (en)
CN (1)	CN1387431A (en)
AU (2)	AU1321401A (en)
BR (1)	BR0015172A (en)
CA (1)	CA2388657A1 (en)
IL (1)	IL149365A0 (en)
MX (1)	MXPA02004334A (en)
NO (1)	NO20022103D0 (en)
SE (1)	SE9903995D0 (en)
WO (2)	WO2001032163A1 (en)
ZA (1)	ZA200203178B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6667344B2 (en)	2001-04-17	2003-12-23	Dey, L.P.	Bronchodilating compositions and methods
US20030055026A1 (en)	2001-04-17	2003-03-20	Dey L.P.	Formoterol/steroid bronchodilating compositions and methods of use thereof
PE20050130A1 (en) *	2002-08-09	2005-03-29	Novartis Ag	ORGANIC COMPOUNDS
GB0312148D0 (en)	2003-05-28	2003-07-02	Aventis Pharma Ltd	Stabilized pharmaceutical products
GB0315889D0 (en)	2003-07-08	2003-08-13	Aventis Pharma Ltd	Stable pharmaceutical products
TWI359675B (en)	2003-07-10	2012-03-11	Dey L P	Bronchodilating β-agonist compositions
JP2007531743A (en) *	2004-04-05	2007-11-08	セプラコアインコーポレーテッド	(R, R) -formoterol in combination with other drugs
ES2245612B1 (en) *	2004-06-29	2007-08-16	Universidad De Barcelona	NEW THERAPEUTIC USE OF FORMOTEROL.
HUE027076T2 (en) *	2005-03-16	2016-08-29	Meda Pharma Gmbh & Co Kg	The combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases
CA2838435A1 (en) *	2011-06-06	2012-12-13	Chiesi Farmaceutici S.P.A.	Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
TR201907092T4 (en) *	2012-12-05	2019-06-21	Chiesi Farm Spa	1-phenyl-2-pyridinyl alkyl alcohol derivatives as phosphodiesterase inhibitors.
JP5846185B2 (en)	2013-11-21	2016-01-20	大日本印刷株式会社	Through electrode substrate and semiconductor device using the through electrode substrate
PT109030B (en) *	2015-12-15	2019-09-25	Hovione Farmaciência, S.A.	PREPARATION OF ZAFIRLUCAST INHALABLE PARTICULES

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9604752D0 (en) *	1996-12-20	1996-12-20	Astra Ab	Formulation and use
WO1998039970A1 (en) *	1997-03-13	1998-09-17	Merck & Co., Inc.	Quinoline leukotriene antagonists
SE9704644D0 (en) *	1997-12-12	1997-12-12	Astra Ab	New use

1999
- 1999-11-03 SE SE9903995A patent/SE9903995D0/en unknown
2000
- 2000-10-27 WO PCT/SE2000/002115 patent/WO2001032163A1/en not_active Ceased
- 2000-10-27 CN CN00815363A patent/CN1387431A/en active Pending
- 2000-10-27 AU AU13214/01A patent/AU1321401A/en not_active Abandoned
- 2000-10-27 IL IL14936500A patent/IL149365A0/en unknown
- 2000-10-27 WO PCT/SE2000/002116 patent/WO2001032166A1/en not_active Ceased
- 2000-10-27 EP EP00975117A patent/EP1242065A1/en not_active Withdrawn
- 2000-10-27 MX MXPA02004334A patent/MXPA02004334A/en unknown
- 2000-10-27 AU AU16526/01A patent/AU1652601A/en not_active Abandoned
- 2000-10-27 KR KR1020027005683A patent/KR20020050254A/en not_active Withdrawn
- 2000-10-27 CA CA002388657A patent/CA2388657A1/en not_active Abandoned
- 2000-10-27 JP JP2001534368A patent/JP2003513037A/en active Pending
- 2000-10-27 BR BR0015172-6A patent/BR0015172A/en not_active Application Discontinuation
2002
- 2002-04-22 ZA ZA200203178A patent/ZA200203178B/en unknown
- 2002-05-02 NO NO20022103A patent/NO20022103D0/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
ZA200203178B (en)	2003-07-22
MXPA02004334A (en)	2002-11-07
IL149365A0 (en)	2002-11-10
EP1242065A1 (en)	2002-09-25
WO2001032163A1 (en)	2001-05-10
AU1321401A (en)	2001-05-14
SE9903995D0 (en)	1999-11-03
CA2388657A1 (en)	2001-05-10
BR0015172A (en)	2002-06-18
AU1652601A (en)	2001-05-14
JP2003513037A (en)	2003-04-08
KR20020050254A (en)	2002-06-26
NO20022103D0 (en)	2002-05-02
WO2001032166A1 (en)	2001-05-10
CN1387431A (en)	2002-12-25

Publication	Publication Date	Title
NO20006220D0 (en)	2000-12-07	<beta> 2-adrenergic receptor agonists
NO20004215D0 (en)	2000-08-23	A pharmaceutical composition comprising an angiotensin II type 2 receptor agonist, and use thereof
DE69800895D1 (en)	2001-07-19	Interleukin-1 receptor antagonist beta (il-1rabeta)
NO20015359L (en)	2001-11-02	New drug formulations based on anti-cholinergically effective compounds and <beta> mimetics
NO960081L (en)	1996-07-10	Estrogen agonist / antagonists
DK1189916T3 (en)	2004-03-22	N-pyrazole A 2A receptor agonists
DE69905248D1 (en)	2003-03-13	NEUROPEPTIDE Y5 RECEPTOR ANTAGONISTS
FR10C0006I2 (en)	2011-04-01	BETA 2-ADRENERGIC RECEPTOR AGONISTS
ATE280157T1 (en)	2004-11-15	4-AROYL-PIPERIDINE-CCR-3 RECEPTOR ANTAGONISTS III
NO20022103D0 (en)	2002-05-02	New combination including a beta 2 (<beta>) 2 andrenoreceptor agonist and leukotriene receptor antagonist
NO20030098L (en)	2003-01-09	<Beta> 3 adrenergic agonists
EP1229910A4 (en)	2003-10-01	INTEGRIN RECEPTOR ANTAGONISTS
AU775774C (en)	2005-05-19	Peroxisome proliferator-activated receptor agonist
NO20010804L (en)	2001-04-11	Muscarinic agonists and antagonists
ATE416173T1 (en)	2008-12-15	1-(3-HETEROARYLPROPYL- OR -PROP-2-ENYL)-4- BENZYLPIPERIDINE AS NMDA RECEPTOR ANTAGONISTS
MA26890A1 (en)	2004-12-20	EESTROGEN AGONIST / ANTAGONIST METABOLITES
NO20004503L (en)	2000-10-10	Vitronectin receptor antagonists
ID26086A (en)	2000-11-23	AZHTICICLIC 5HT1 RECEPTOR LIGANS
IL138576A0 (en)	2001-10-31	A novel interleukin-1 receptor antagonist and uses thereof
DK1146874T3 (en)	2005-01-31	Vitronectin receptor agonist
IL137428A0 (en)	2001-07-24	Estrogen agonists and antagonists for multiple indications
NO20013978L (en)	2001-08-15	Dopamine D1 receptor agonist compounds
NO20035319D0 (en)	2003-11-28	A G protein-coupled receptor and its use
SE0003995D0 (en)	2000-11-01	Receptor agonists and antagonists
DE69830671D1 (en)	2005-07-28	Integrin receptor Antagonist

Legal Events

Date	Code	Title	Description
2004-10-18	FC2A	Withdrawal, rejection or dismissal of laid open patent application